Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Current Assets (2021 - 2026)

Envoy Medical's Current Assets history spans 6 years, with the latest figure at $27.7 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 233.04% to $27.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.7 million, a 233.04% increase, with the full-year FY2025 number at $6.3 million, down 29.42% from a year prior.
  • Current Assets hit $27.7 million in Q1 2026 for Envoy Medical, up from $6.3 million in the prior quarter.
  • Over the last five years, Current Assets for COCH hit a ceiling of $27.7 million in Q1 2026 and a floor of $397697.0 in Q2 2023.
  • Historically, Current Assets has averaged $6.9 million across 5 years, with a median of $6.3 million in 2025.
  • Biggest five-year swings in Current Assets: surged 3346.84% in 2023 and later plummeted 64.92% in 2024.
  • Tracing COCH's Current Assets over 5 years: stood at $1.6 million in 2022, then skyrocketed by 352.43% to $7.5 million in 2023, then increased by 19.31% to $8.9 million in 2024, then fell by 29.42% to $6.3 million in 2025, then surged by 340.87% to $27.7 million in 2026.
  • Business Quant data shows Current Assets for COCH at $27.7 million in Q1 2026, $6.3 million in Q4 2025, and $5.8 million in Q3 2025.